Tag: Regulation

Cambodia's Life Insurance Market Sees Moderate Growth, Forte Life Achieves Profitability in 2025

Cambodia's life insurance sector shows steady growth in 2025 with Forte Life Assurance turning profitable. Improved bancassurance regulations and digital distribution drive market expansion amid economic shifts.

Judge Temporarily Blocks ACA Marketplace Changes Affecting UnitedHealth

A federal judge temporarily pauses ACA marketplace changes impacting major insurers like UnitedHealth, offering relief amid regulatory shifts. Insights on market and compliance effects.

Cycling Fatalities Rise in Connecticut Amid E-Bike Popularity and Regulatory Challenges

Connecticut sees rising cyclist fatalities linked to e-bike use amid regulatory gaps. Increased riding popularity and safety concerns impact insurers and policymakers.

Pennsylvania ACA Marketplace Proposes Nearly 19% Health Insurance Premium Increase for 2026

Pennsylvania health insurers have proposed an average 19% increase in ACA marketplace premiums for 2026. Public feedback is invited by the state Insurance Department ahead of the rate review process.

U.S. Economy Faces Employment Stagnation, Inflation, and Market Uncertainty in 2025

Explore key factors impacting the U.S. economy in 2025 including employment slowdowns, inflation trends, tariff effects, wage stagnation, and corporate investment shifts amid regulatory changes.

Colorado Car Insurance Among Nation's Costliest as Tariff Impacts Loom

Colorado's car insurance ranks seventh highest in the U.S. with steady premiums early in 2025 but tariff-related cost pressures could raise rates by up to 7% by year-end, according to Insurify.

UnitedHealth to Divest Assets in $3.3B Amedisys Acquisition to Preserve Competition

UnitedHealth Group settles with US Justice Department requiring divestiture of 164 home health and hospice facilities in $3.3 billion Amedisys acquisition to maintain market competition and compliance.

Congressional Opposition Mounts Against CMS Medicare Prior Authorization Expansion

Congresswoman Maggie Goodlander and colleagues urge CMS to halt the proposed expansion of prior authorization in Traditional Medicare, citing risks to patient care and administrative burdens.

CMS Proposes Voluntary Medicaid and Medicare GLP-1 Coverage Trial

CMS plans a voluntary five-year trial allowing state Medicaid and Medicare Part D plans to cover GLP-1 weight management drugs, including Ozempic and Wegovy, starting in 2026-27 amid pricing and coverage challenges.

Medicare Weight Loss Drug Coverage: Legislative and Regulatory Paths

Medicare faces evolving opportunities and challenges in covering weight loss drugs through legislation like the Treat and Reduce Obesity Act and federal demonstration projects. Drug adherence and cost-effectiveness remain key issues.